Celadon Pharmaceuticals Plc announced that, following the signing of an introductory sales contract with a long-established American business, it has successfully shipped two different medical cannabis products to the United States, representing the Company's first international commercial supply. The American business is a supplier to a number of different US Government departments, and this initial sale has the potential to grow into a material source of additional revenue. The product has been supplied from the Company's UK facility.